• 21 Dec 2020
Annual Reports and Related Documents
  • 09 Dec 2020
Resignation Of An Independent Director And Changes To The Composition Of The Board And RC
  • 09 Dec 2020
Announcement Of Cessation :: Resignation Of Independent Director
  • 26 Nov 2020
Distribution Agreement With Joysbio & Expansion Of Ongoing Sale And Distribution Of Products
  • 26 Nov 2020
Covid-19 Antibody Test Kits: Receipt Of Product Authorisation In Indonesia
  • 05 Nov 2020
Correction In Announcement Relating To The Update On Issuance Of Lod To Sysmex
  • 05 Nov 2020
Update On Issuance Of Letter Of Demand To Sysmex Corporation
  • 16 Oct 2020
Issuance Of Letter Of Demand To Sysmex Corporation
  • 31 Aug 2020
Proposed Issuance Of Up To 2,723,500 Shares - Allotment And Issuance Of 1,168,000 Shares
  • 30 Aug 2020
Proposed Issuance Of Up To 2,723,500 Shares - Receipt Of Listing And Quotation Notice
  • 21 Aug 2020
Response To SGX Queries
  • 19 Aug 2020
Disclosure Of Interest/ Changes In Interest Of Substantial Shareholder(s)/ Unitholder(s) - Disclosure In Change Of Interest Of Substantial Shareholder(s) - Clearbridge BSA Pte. Ltd.
  • 19 Aug 2020
Disclosure Of Interest/ Changes In Interest Of Director/ Chief Executive Officer - Changes In Director's Interest - Yee Pinh Jeremy
  • 19 Aug 2020
Allotment And Issuance Of New Shares Pursuant To The Vesting Of Share Awards Under The PSP
  • 18 Aug 2020
Disclosure Of Interest/ Changes In Interest Of Director/ Chief Executive Officer - Changes In Director's Interest - Yee Pinh Jeremy
  • 18 Aug 2020
Proposed Issuance Of Up To 2,723,500 New Ordinary Shares In Biolidics
  • 18 Aug 2020
Grant Of Share Awards Pursuant To The Biolidics Performance Share Plan
  • 14 Aug 2020
Announcement Pursuant To Rule 706A Of The Listing Manual
  • 14 Aug 2020
Biolidics Records A Six-fold Increase In Revenue With Positive EBITDA Of S$0.30 Million Achieved In HY FY2020
  • 14 Aug 2020
Financial Statements and Related Announcement - Half Yearly Results
  • 16 Jul 2020
Response To SGX Queries
  • 15 Jul 2020
Queries By SGX RegCo On The Company's Announcement Of 14 July 2020
  • 15 Jul 2020
Request For Lifting Of Trading Halt - Sponsor's Statement
  • 15 Jul 2020
Request For Lifting Of Trading Halt - Request For Lifting Of Trading Halt
  • 14 Jul 2020
Licence Agreement With Accelerate Technologies Pte Ltd
  • 13 Jul 2020
Request For Trading Halt - Request For Trading Halt
  • 09 Jul 2020
Response To SGX Queries
  • 08 Jul 2020
Collaboration With LC-Bio Technologies (Hangzhou) Co., Ltd.
  • 03 Jul 2020
Response To SGX Queries
  • 02 Jul 2020
COVID-19 Antibody Test Kits: Further Us Market Update
  • 28 Jun 2020
COVID-19 Antibody Test Kits: US Market Update
  • 26 May 2020
Proposed Acquisition Of The Entire Share Capital Of Biomedics Laboratory Pte. Ltd. - Completion
  • 19 May 2020
Minutes Of Annual General Meeting Held On 30 April 2020
  • 19 May 2020
Minutes Of Extraordinary General Meeting Held On 30 April 2020
  • 11 May 2020
Appointment Of Clearbridge Medical Group Pte Ltd As Non-Exclusive Distributor
  • 08 May 2020
Mediproud Appointed As Non-exclusive Distributor Of Biolidics' COVID-19 Test Kits In Thailand
  • 30 Apr 2020
Extraordinary/ Special General Meeting - Voluntary
  • 30 Apr 2020
Annual General Meeting
  • 26 Apr 2020
Response To SGX Queries
  • 26 Apr 2020
Response To Questions Received From Shareholders And SIAS Prior To The Company's AGM And EGM
  • 23 Apr 2020
Appointment Of AYTU Bioscience As Exclusive Distributor For Biolidics' COVID-19 Rapid Test Kits
  • 23 Apr 2020
Request For Lifting Of Trading Halt
  • 23 Apr 2020
Request For Lifting Of Trading Halt - Sponsor's Statement
  • 22 Apr 2020
Query Regarding Trading Activity
  • 22 Apr 2020
Request For Trading Halt
  • 22 Apr 2020
Response To SGX Queries
  • 20 Apr 2020
Policy D Notification To The U.S. FDA For Biolidics' COVID-19 Rapid Test Kits-completion Of Listing
  • 15 Apr 2020
REPL - Extraordinary/ Special General Meeting - Voluntary
  • 15 Apr 2020
CK Life Sciences Appointed As A Non-exclusive Distributor For Biolidics' COVID-19 Kits
  • 15 Apr 2020
REPL - Annual General Meeting - Voluntary
  • 13 Apr 2020
Additional Arrangements For AGM And EGM To Be Held On 30 April 2020
  • 13 Apr 2020
Notification To The U.S. FDA For The Intended Distribution Of Biolidics' Covid-19 Rapid Test Kits
  • 09 Apr 2020
Response to SGX Queries
  • 08 Apr 2020
Additional Arrangement For AGM And EGM To Be Held On 30 April 2020
  • 08 Apr 2020
Extraordinary/ Special General Meeting - Voluntary
  • 08 Apr 2020
Annual General Meeting - Voluntary
  • 08 Apr 2020
Annual Reports and Related Documents
  • 06 Apr 2020
Rapid Test Kit For COVID-19 Obtains CE Marking For Use In The European Union
  • 01 Apr 2020
Biolidics' Rapid Test Kit For COVID-19 Approved For Use By The Food And Drug Administration Of The Philippines
  • 01 Apr 2020
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s) - Cease to be a Substantial Shareholder - BV Healthcare II Pte. Ltd.
  • 30 Mar 2020
Biolidics To Launch Its Rapid Test Kit For COVID-19; Obtains Approval From Singapore’s Health Sciences Authority For Its Rapid Test Kit To Be Used In Singapore
  • 30 Mar 2020
Signing Of Manufacturer Agreement For Rapid Test Kits To Detect Novel Coronavirus 2019
  • 27 Mar 2020
Biolidics To Acquire Laboratory & Diagnostic Testing Business In Singapore To Enhance Its Commercialisation Capabilities And Expand Its Revenue Model
  • 27 Mar 2020
Proposed Acquisition Of The Entire Issued And Paid-up Ordinary Shares In The Capital Of Biomedics Laboratory Pte. Ltd.
  • 27 Mar 2020
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s) :: Disclosure of Change in Interest of Substantial Shareholder - SEEDS
  • 27 Mar 2020
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s) :: Disclosure of Change in Interest of Substantial Shareholder - CBSA
  • 27 Mar 2020
Completion of Proposed Placement of 17,858,000 New Ordinary Shares in the Capital of Biolidics
  • 26 Mar 2020
Receipt Of Listing And Quotation Notice - Proposed Placement Of 17,858,000 New Ordinary Shares
  • 23 Mar 2020
Re-designation of Chief Commercial Officer as Interim Chief Executive Officer
  • 16 Mar 2020
Proposed Placement Of 17,858,000 New Ordinary Shares In The Capital Of Biolidics Limited
  • 28 Feb 2020
Biolidics To Develop Its Proprietary Cancer Diagnostics Solutions In China
  • 27 Feb 2020
Financial Statements and Related Announcement - Full Yearly Results
Locate Us
Contact Us
Link In Link In
© 2024 Biolidics Limited
All Rights Reserved

About Biolidics

Contact Us

18 Howard Road
#11-09 Novelty BizCentre,
Singapore 369585
Tel: 64820668